Cysteine

半胱氨酸

Report date: 2023/07/26 15:17:33

Base Information

Drug NameCysteine
Drug Alias NameCysteine, L-L-巯基丙氨酸L-(+)-Cysteine(S)-2-氨基-3-巯基丙酸L-Alanine, 3-mercapto- +[16] 
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionAmino acid replacements
TargetsNot applicable
Therapy Area/IndicationsParenteral NutritionKidney Failure, ChronicAcute Kidney Injury +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsParenteral NutritionKidney Failure, ChronicAcute Kidney Injury +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeB02AAB05BA01B05XB
Related LinksN/A